ZyVersa Therapeutics, Inc. (ZVSA)
ZVSA Stock Price Chart
Explore ZyVersa Therapeutics, Inc. interactive price chart. Choose custom timeframes to analyze ZVSA price movements and trends.
ZVSA Company Profile
Discover essential business fundamentals and corporate details for ZyVersa Therapeutics, Inc. (ZVSA) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
11 Feb 2022
Employees
7.00
Website
https://www.zyversa.comCEO
Stephen C. Glover
Description
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.
ZVSA Financial Timeline
Browse a chronological timeline of ZyVersa Therapeutics, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 25 Mar 2026
Upcoming earnings on 13 Nov 2025
Earnings released on 13 Aug 2025
EPS came in at -$0.46 .
Earnings released on 12 May 2025
EPS came in at -$0.73 falling short of the estimated -$0.40 by -82.50%.
Earnings released on 31 Mar 2025
EPS came in at -$1.31 surpassing the estimated -$2.73 by +52.02%, while revenue for the quarter reached $26.08K .
Earnings released on 14 Nov 2024
EPS came in at -$2.43 surpassing the estimated -$5.80 by +58.10%.
Earnings released on 9 Aug 2024
EPS came in at -$3.31 surpassing the estimated -$5.20 by +36.35%.
Earnings released on 15 May 2024
EPS came in at -$4.53 falling short of the estimated -$3.70 by -22.43%.
Stock split effective on 26 Apr 2024
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 26 Mar 2024
EPS came in at -$13.68 falling short of the estimated -$2.14 by -539.25%, while revenue for the quarter reached $15.60K .
Stock split effective on 5 Dec 2023
Shares were split 1 : 35 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 14 Nov 2023
EPS came in at -$31.47 surpassing the estimated -$55.94 by +43.74%.
Earnings released on 21 Aug 2023
EPS came in at -$1.46K .
Earnings released on 12 May 2023
EPS came in at -$0.39 .
Earnings released on 31 Mar 2023
EPS came in at -$184.55 .
Earnings released on 30 Sept 2022
EPS came in at -$80.34 .
Earnings released on 15 Aug 2022
EPS came in at -$38.54 .
Earnings released on 12 May 2022
EPS came in at -$78.69 .
Earnings released on 31 Dec 2021
EPS came in at -$68.72 .
Earnings released on 30 Sept 2021
EPS came in at -$40.38 .
Earnings released on 30 Jun 2021
EPS came in at -$45.00 .
Earnings released on 31 Mar 2021
EPS came in at -$45.97 .
ZVSA Stock Performance
Access detailed ZVSA performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.